The Multidisciplinary Association for Psychedelic Studies (MAPS) is pivoting its focus to state-level initiatives following ...

Critics addressed the elephant in the room during the FDA’s first public meeting on trauma since its decision to delay ...

Assessing the ability of psychedelics to enhance evidence-based treatments like PE and MPE, which have a large base of ...

Privately-owned Lykos Therapeutics continues to reel from its devastating rejection by the Food and Drug Administration (FDA) ...

Lykos Therapeutics CEO Amy Emerson steps down following the FDA's rejection of the company's MDMA-based PTSD therapy.

The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

The Food and Drug Administration (FDA) declined to approve a new drug application submitted in February by Lykos Therapeutics ...

Psychedelics were high on the agenda for an official panel and public commenters, including the fallout from the FDA's MDMA ...

In April, HHS’ Office for Civil Rights issued a final rule that said health providers can’t discriminate against patients by ...

The House late Monday passed legislation that would effectively prohibit Chinese biotech companies from doing business in the U.S. in a bipartisan 306-81 vote Monday.

This Kentucky Republican won't stop until he finds a state willing to make legal room for ibogaine, a drug he calls "God's ...